The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews

Cited by (1,000)

Items 201–300 of 1,000

  1. Assessment of Cognitive Brain Function in Ecstasy Users and Contributions of Other Drugs of Abuse: Results from an fMRI Study
    Gerry Jager, Maartje M. L. de Win, Ingeborg van der Tweel, Thelma Schilt, René S. Kahn, Wim van den Brink, Jan M. van Ree, Nick F. Ramsey · 2007 · Neuropsychopharmacology
  2. Psychostimulants and monoamine transporters: upsetting the balance
    J. Martin Elliott, Thomas J.R. Beveridge · 2004 · Current Opinion in Pharmacology
  3. Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons
    Mechan, Annis, Yuan, Jie, Hatzidimitriou, George, Irvine, Rodney J, McCann, Una D, Ricaurte, George A · 2006 · Neuropsychopharmacology
  4. Neurotoxicity of MDMA: Main effects and mechanisms
    Giulia Costa, Krystyna Gołembiowska · 2021 · Experimental Neurology
  5. Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones
    Verónica Sánchez, Esther O’Shea, Kathryn S. Saadat, J. Martin Elliott, M. Isabel Colado, A. Richard Green · 2004 · Journal of Psychopharmacology
  6. Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review
    Rianne A. de Kleine, BARBARA OLASOV ROTHBAUM, Agnes van Minnen · 2013 · European Journal of Psychotraumatology
  7. Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users
    Andrew C. Parrott · 2009 · Neuropsychobiology
  8. Nitrotyrosine as a marker for peroxynitrite‐induced neurotoxicity: the beginning or the end of the end of dopamine neurons?
    Donald M. Kuhn, Stacey A. Sakowski, Mahdieh Sadidi, Timothy J. Geddes · 2004 · Journal of Neurochemistry
  9. A reliable model of intravenous MDMA self-administration in naïve mice
    José Manuel Trigo, Fany Panayi, Guadalupe Sòria, Rafael J. Maldonado, Patricia Robledo · 2005 · Psychopharmacology
  10. Effects of MDMA on body temperature in humans
    Matthias E. Liechti · 2014 · Temperature
  11. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats
    Maria Åberg, Dean Wade, Erin Wall, Sari Izenwasser · 2006 · Neurotoxicology and Teratology
  12. Electrochemical detection of 3,4-methylenedioxymethamphetamine (ecstasy) using a boron-doped diamond electrode with differential pulse voltammetry: Simple and fast screening method for application in forensic analysis
    Karine Rocha Teófilo, Luciano Chaves Arantes, Pablo Alves Marinho, Anne Alves Macedo, Dilton Martins Pimentel, Diego P. Rocha, Anderson C. de Oliveira, Eduardo Mathias Richter, Rodrigo A.A. Muñoz, Wallans Torres Pio dos Santos · 2020 · Microchemical Journal
  13. Developmental effects of 3,4-methylenedioxymethamphetamine: a review
    Matthew R. Skelton, Michael T. Williams, Charles V. Vorhees · 2008 · Behavioural Pharmacology
  14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (“Ecstasy”) and MDA (“Love”)
    Ruth McNamara, Aoife Kerans, Barry Vincent O’Neill, Andrew Harkin · 2005 · Neuropharmacology
  15. Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: Lessons from the serotonergic modulation of action selection, learning, affect, and social cognition
    Clark Roberts, Barbara Jacquelyn Sahakian, Trevor William Robbins · 2020 · Neuroscience & Biobehavioral Reviews
  16. Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion
    Craig P. Motbey, Emily Aspasia Karanges, Kong M. Li, Shane M. Wilkinson, ADAM R. WINSTOCK, John Ramsay, Callum Hicks, Michael D. Kendig, Naomi A. Wyatt, Paul D. Callaghan et al. · 2012 · PLoS ONE
  17. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study
    Jacqui Rodgers, Tom Buchanan, Carol Pearson, Andy C. Parrott, Jonathan Ling, Tom Heffernan, Andrew B Scholey · 2006 · Journal of Psychopharmacology
  18. The emerging role of psilocybin and MDMA in the treatment of mental illness
    Hartej Gill, Barjot Gill, David C. J. Chen-Li, Sabine El‐Halabi, Nelson B. Rodrigues, Danielle S. Cha, Orly Lipsitz, Yena L. Lee, Joshua Daniel Rosenblat, Amna Majeed et al. · 2020 · Expert Review of Neurotherapeutics
  19. 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system
    Daniela Braida, Stefania Iosuè, Simona Pegorini, Mariaelvina Sala · 2004 · Pharmacological Research
  20. Differential Effects of Ecstasy on Short-Term and Working Memory: A Meta-Analysis
    Claire E. Nulsen, Allison M. Fox, Geoffrey R. Hammond · 2010 · Neuropsychology Review
  21. MDMA and fenfluramine reduce L‐DOPA‐induced dyskinesia via indirect 5‐HT1A receptor stimulation
    Christopher Bishop, Jennifer L. Taylor, Donald M. Kuhn, Karen L. Eskow Jaunarajs, John Y. Park, Paul D. Walker · 2006 · European Journal of Neuroscience
  22. Oxidative Stress and Drugs of Abuse: An Update
    Teresa Cunha‐Oliveira, Ana Cristina Rego, Catarina Resende Oliveira · 2013 · Mini-Reviews in Organic Chemistry
  23. Patterns of use and harm reduction practices of ecstasy users in Australia
    Kelly Allott, Jennifer R. Redman · 2005 · Drug and Alcohol Dependence
  24. Ecstasy: Pharmacodynamic and Pharmacokinetic Interactions
    Jessica R. Oesterheld, Scott C. Armstrong, Kelly L. Cozza · 2004 · Psychosomatics
  25. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends
    Marit Edland-Gryt, Sveinung Sandberg, Willy Pedersen · 2017 · International Journal of Drug Policy
  26. MDMA: On the translation from rodent to human dosing
    A. Richard Green, Johan Gabrielsson, Charles Alexander Marsden, Kevin C.F. Fone · 2009 · Psychopharmacology
  27. The Potential Dangers of Using MDMA for Psychotherapy
    Andrew C. Parrott · 2014 · Journal of Psychoactive Drugs
  28. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice
    Noelia Granado, Isabel Escobedo, Esther O’Shea, M. Isabel Colado, Rosario Moratalla · 2007 · Synapse
  29. Episodic Memories and Their Relevance for Psychoactive Drug Use and Addiction
    Christian P. Müller · 2013 · Frontiers in Behavioral Neuroscience
  30. Plasma Drug Concentrations and Physiological Measures in ‘Dance Party’ Participants
    Rodney James Irvine, Michael John Keane, PETER D. FELGATE, Una D. McCann, Paul D. Callaghan, Jason M. White · 2005 · Neuropsychopharmacology
  31. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study
    Susana de Sola Llopis, Mónica Miguélez, Jordi Peña‐Casanova, Sandra Poudevida, Magı́ Farré, Roberta Pacifici, P. Böhm, Sergio Abanades, Antonio Verdejo‐García, Klaus Langohr et al. · 2008 · Journal of Psychopharmacology
  32. Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
    Sascha B. Thal, Miriam J.J. Lommen · 2018 · Journal of Contemporary Psychotherapy
  33. Caffeine provokes adverse interactions with 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and related psychostimulants: mechanisms and mediators
    Natacha Vanattou‐Saïfoudine, Ruth McNamara, Andrew Harkin · 2012 · British Journal of Pharmacology
  34. Acquisition of MDMA self‐administration: pharmacokinetic factors and MDMA ‐induced serotonin release
    Sarah Bradbury, Judith Bird, Joyce Colussi‐Mas, Melanie Mueller, George A. Ricaurte, Susan Schenk · 2013 · Addiction Biology
  35. An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis
    Diana Dias da Silva, Helena Carmo, Adam E. Lynch, Elisabete A. Silva · 2013 · Archives of Toxicology
  36. Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats
    Kirsten C. Morley, Kong M. Li, Glenn E. Hunt, Paul E. Mallet, Iain S. McGregor · 2004 · Neuropharmacology
  37. Brain serotonin transporter binding in former users of MDMA (‘ecstasy’)
    Sudhakar Selvaraj, Rosa Hoshi, Zubin Bhagwagar, Naga Venkatesha Murthy, Rainer Hinz, Philip J. Cowen, H. Valerie Curran, Paul M. Grasby · 2009 · The British Journal of Psychiatry
  38. Brain Hyperthermia During Physiological and Pathological Conditions: Causes, Mechanisms, and Functional Implications
    Eugene A. Kiyatkin · 2004 · Current Neurovascular Research
  39. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo
    Johanson, Chris-Ellyn, Kilbey, Marlyne, Gatchalian, Kristin, Tancer, Manuel · 2006 · Drug and Alcohol Dependence
  40. Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
    Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes, Renato Filev · 2022 · Addiction Neuroscience
  41. MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature
    Esther O’Shea, Laura Orío, Isabel Escobedo, Verónica Sánchez, Jorge Camarero, Alfred Richard Green, María Isabel Colado · 2006 · British Journal of Pharmacology
  42. A translational pharmacology approach to understanding the predictive value of abuse potential assessments
    David B. Horton, David M. Potter, Andy N. Mead · 2013 · Behavioural Pharmacology
  43. Use and abuse of dissociative and psychedelic drugs in adolescence
    M.L. Shawn Bates, Keith A. Trujillo · 2021 · Pharmacology Biochemistry and Behavior
  44. Alterations in Body Temperature, Corticosterone, and Behavior Following the Administration of 5-Methoxy-Diisopropyltryptamine (‘Foxy’) to Adult Rats: a New Drug of Abuse
    Michael T. Williams, Nicole R. Herring, Tori L. Schaefer, Matthew R. Skelton, Nicholas G. Campbell, Jack W. Lipton, Anne E McCrea, Charles V. Vorhees · 2006 · Neuropsychopharmacology
  45. Dancing with “Death”: P-Methoxyamphetamine Overdose and Its Acute Management
    David G. E. Caldicott, Nicholas A. Edwards, Amanda Kruys, K. Paul Kirkbride, D. Noel Sims, Roger W. Byard, Michael Prior, R Julian Irvine · 2003 · Journal of Toxicology Clinical Toxicology
  46. Systemic enhancement of serotonin signaling reverses social deficits in multiple mouse models for ASD
    Walsh, Jessica J., Llorach, Pierre, Cardozo Pinto, Daniel F., Wenderski, Wendy, Christoffel, Daniel J., Salgado, Juliana S., Heifets, Boris D., Crabtree, Gerald R., Malenka, Robert C. · 2021 · Neuropsychopharmacology
  47. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice
    Thibault Renoir, Eleni Païzanis, Malika El Yacoubi, Françoise Saurini, Naı̈ma Hanoun, Maxette Melfort, Klaus‐Peter Lesch, M. Hamon, Laurence Lanfumey · 2008 · The International Journal of Neuropsychopharmacology
  48. Effect of 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) on dopamine transmission in the nucleus accumbens shell and core
    Cristina Cadoni, Marcello Solinas, Augusta Pisanu, Gerald Zernig, Elio Acquas, G. Di Chiara · 2005 · Brain Research
  49. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users
    Thelma Schilt, Maartje M. L. de Win, Gerry Jager, Maarten W.J. Koeter, Nick F. Ramsey, Ben A. Schmand, Wim van den Brink · 2007 · Psychological Medicine
  50. Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain
    Amit Khairnar, Antonio Plumitallo, Lucia Frau, Nicoletta Schintu, Micaela Morelli · 2009 · Neurotoxicity Research
  51. Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Kelly Allott, Jennifer R. Redman · 2006 · Neuroscience & Biobehavioral Reviews
  52. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users
    Rüssel S. Falck, Robert Gideon Carlson, Jichuan Wang, Harvey Alan Siegal · 2004 · Drug and Alcohol Dependence
  53. Direct influence of serotonin on the larval heart of Drosophila melanogaster
    Sameera Dasari, Robin Lewis Cooper · 2005 · Journal of Comparative Physiology B
  54. A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
    Marco Solmi, Chaomei Chen, Charles Dauré, Anne Buot, Michael Ljuslin, Vincent Verroust, Luc Mallet, Yasser Khazaal, Stéphane Rothen, Gabriel Thorens et al. · 2022 · European Neuropsychopharmacology
  55. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function
    H. Valerie Curran, Suzanne L. Verheyden · 2003 · Psychopharmacology
  56. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents
    Carlos Chipana, I TORRES, Jorge Camarasa, David Pubill, Elena Escubedo · 2008 · Neuropharmacology
  57. THC Prevents MDMA Neurotoxicity in Mice
    Clara Touriño, Andreas Zimmer, Olga Valverde · 2010 · PLoS ONE
  58. Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA
    Brigitta Balogh, Eszter Molnár, Rita Jakus, Linda Quate, Henry J. Olverman, Paul A. T. Kelly, Sándor Kántor, György Bagdy · 2004 · Psychopharmacology
  59. A prospective study of learning, memory, and executive function in new MDMA users
    Daniel R. Wagner, Benjamin Becker, Philip Koester, Euphrosyne Gouzoulis‐Mayfrank, Jörg Daumann · 2012 · Addiction
  60. MDMA (“ecstasy”) abuse as an example of dopamine neuroplasticity
    Susan Schenk · 2010 · Neuroscience & Biobehavioral Reviews
  61. A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)
    Brian J. Piper · 2006 · Neurotoxicology and Teratology
  62. Methods to produce hyperthermia-induced brain dysfunction
    Hari Shanker Sharma · 2007 · Progress in brain research
  63. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity
    E Bull · 2003 · Neuropharmacology
  64. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge’ ingestion) low dose of MDMA
    A. Richard Green, Verónica Sánchez, Esther O’Shea, Kathryn S. Saadat, J. Martin Elliott, María Isabel Colado · 2004 · Psychopharmacology
  65. DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy)
    Francesco Fornai, Paola Lenzi, Giada Frenzilli, Marco Gesi, Michela Ferrucci, Gloria Lazzeri, Francesca Biagioni, Marco Nigro, Alessandra Falleni, Mario Giusiani et al. · 2004 · Psychopharmacology
  66. Mental disorders in current and former heavy ecstasy (MDMA) users
    Rainer Thomasius, Kay Uwe Petersen, Pavlina Zapletalova, Lutz Wartberg, Dirk Zeichner, Achim Schmoldt · 2005 · Addiction
  67. MPTP‐induced dopamine neuron degeneration and glia activation is potentiated in MDMA‐pretreated mice
    Giulia Costa, Lucia Frau, Jadwiga Wardas, Annalisa Pinna, Antonio Plumitallo, Micaela Morelli · 2013 · Movement Disorders
  68. Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats
    Mar�a Ramos, Beatriz Goñi‐Allo, Norberto Aguirre · 2004 · Psychopharmacology
  69. Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats
    Marta Barenys, Nuria Macia, Lydia Camps, Joaquín de Lapuente, Jesús Gómez-Catalán, Javier González-Linares, Miquel Borràs, Miguel Rodamilans, Juan M. Llobet · 2009 · Toxicology Letters
  70. Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice
    Manuel Daza‐Losada, Marta Rodríguez‐Arias, C. Maldonado, M.A. Aguilar, Consuelo Guerri, José Miñarro · 2008 · Neurotoxicology and Teratology
  71. Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans
    Gabrielle Todd, Carolyn Noyes, Stanley C. Flavel, Chris B. Della Vedova, Peter Spyropoulos, Barry E. Chatterton, Daniela Berg, Jason M. White · 2013 · PLoS ONE
  72. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET
    I‐Hsun Li, Wen-Sheng Huang, Chyng‐Yann Shiue, Ya-Yao Huang, Ren-Shyan Liu, San‐Chong Chyueh, Shih-Hsiung Hu, Mei-Hsiu Liao, Lie‐Hang Shen, Jiang-Chuan Liu et al. · 2009 · NeuroImage
  73. The ups and downs of ecstasy
    Erika Check · 2004 · Nature
  74. MDMA Increases Glutamate Release and Reduces Parvalbumin-Positive GABAergic Cells in the Dorsal Hippocampus of the Rat: Role of Cyclooxygenase
    John H. Anneken, Jacobi I. Cunningham, Stuart A. Collins, Bryan K. Yamamoto, Gary A. Gudelsky · 2012 · Journal of Neuroimmune Pharmacology
  75. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
    Benjamin J. G. Illingworth, Declan J Lewis, Andrew T. Lambarth, Kate Stocking, James MN Duffy, Luke A. Jelen, James Rucker · 2020 · Journal of Psychopharmacology
  76. A ‘Rave’ Review: Conceptual Interests and Analytical Shifts in Research on Rave Culture
    Tammy L. Anderson, Philip R. Kavanaugh · 2007 · Sociology Compass
  77. Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA
    Felix Hasler, Erich Studerus, K. Lindner, S. Ludewig, F.X. Vollenweider · 2008 · Journal of Psychopharmacology
  78. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use
    Euphrosyne Gouzoulis‐Mayfrank, Thomas Fischermann, Markus Rezk, Bastian Thimm, Gernot Hensen, Jörg Daumann · 2005 · Drug and Alcohol Dependence
  79. The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis
    Dominik K. Biezonski, Jerrold S. Meyer · 2011 · Current Neuropharmacology
  80. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China
    Yangyang Zhang, Changli Lu, Jun Zhang, Hu Li, Hui Song, Jing Li, Lin Kang · 2012 · Addictive Behaviors
  81. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635
    Glenn E. Hunt, Iain S. McGregor, Jennifer Louise Cornish, Paul D. Callaghan · 2011 · Brain Research Bulletin
  82. Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats
    William Walter Blessing, Angela Zilm, Youichirou Ootsuka · 2006 · Neuroscience
  83. Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug–drug interactions
    Saskia J. Rietjens, Laura Hondebrink, Remco H.S. Westerink, Jan Meulenbelt · 2012 · Critical Reviews in Toxicology
  84. The Toxicology of New Psychoactive Substances
    Elli Tyrkkö, Mikael Andersson, Robert Kronstrand · 2015 · Therapeutic Drug Monitoring
  85. Crystal Methamphetamine and Ecstasy Differ in Relation to Unsafe Sex Among Young Gay Men
    Arn J. Schilder, Thomas M. Lampinen, Mary Lou Miller, Robert S. Hogg · 2005 · Canadian Journal of Public Health
  86. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns
    Csaba Ádori, Rómeó D. Andó, Gábor Géza Kovács, György Bagdy · 2006 · The Journal of Comparative Neurology
  87. Neurotoxic effects of MDMA (“ecstasy”) administration to neonatal rats
    Jerrold S. Meyer, Mark Grande, Kenneth M. Johnson, Syed F. Ali · 2004 · International Journal of Developmental Neuroscience
  88. Enhanced Tau Phosphorylation in the Hippocampus of Mice Treated with 3,4-Methylenedioxymethamphetamine (“Ecstasy”)
    Carla Letizia Busceti, Francesca Biagioni, Barbara Riozzi, Giuseppe Battaglia, Marianna Storto, Carlo Cinque, Gemma Molinaro, Roberto Gradini, Andrea Caricasole, Anna Maria Canudas et al. · 2008 · Journal of Neuroscience
  89. Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia
    Sinead E. Shortall, Andrew R. Green, KM Swift, Kevin C.F. Fone, Madeleine V. King · 2012 · British Journal of Pharmacology
  90. Neural and Cardiac Toxicities Associated With 3,4-Methylenedioxymethamphetamine (MDMA)
    Michael H. Baumann, Richard B. Rothman · 2009 · International review of neurobiology
  91. Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine
    Joyce Colussi‐Mas, Richard J. Wise, Alex Howard, Susan Schenk · 2010 · The International Journal of Neuropsychopharmacology
  92. Separating the agony from ecstasy: R(–)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice
    Daniel W. Curry, Matthew B. Young, Andrew Tran, Georges E. Daoud, Leonard Lee Howell · 2017 · Neuropharmacology
  93. Serotonin/dopamine interaction in learning
    María Esther Olvera‐Cortés, Patricia B. Anguiano-Rodríguez, Miguel Angel López‐Vázquez, Jorge S. Alfaro · 2008 · Progress in brain research
  94. Behavioral genetic contributions to the study of addiction-related amphetamine effects
    Tamara J. Phillips, Helen M. Kamens, Jeanna M. Wheeler · 2007 · Neuroscience & Biobehavioral Reviews
  95. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study
    Gerry Jager, Maartje M. L. de Win, Hylke Vervaeke, Thelma Schilt, René S. Kahn, Wim van den Brink, Jan M. van Ree, Nick F. Ramsey · 2007 · Psychopharmacology
  96. Legal piperazine‐containing party pills‐a new trend in substance misuse
    Janie L. Sheridan, Rachael Butler, Chris Wilkins, Bruce Russell · 2007 · Drug and Alcohol Review
  97. Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers
    Glenn Dumont, Elke Wezenberg, M. M. G. J. Valkenberg, C.A.J. de Jong, Jan K. Buitelaar, Joop van Gerven, Robbert Jan Verkes · 2008 · Psychopharmacology
  98. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia
    Manish M. Patel, Martin G. Belson, Adam B. Longwater, Kent R. Olson, Michael A. Miller · 2005 · Journal of Emergency Medicine
  99. Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle
    Rick S. Shin, Mei Qin, Zhonghua Liu, Satoshi Ikemoto · 2008 · Psychopharmacology
  100. Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers
    Una D. McCann, Francis P. Sgambati, Alan R. Schwartz, George A. Ricaurte · 2009 · Neurology